Hello, stox
I was actually unaware of the elated discussion in progress at the time of my posting last night. I very seldom follow the threads. As time has progressed, I find that my attention has been refined, and focused on those who best represent the pro and con arguments. Specifically, I do my best to evaluate what you and David Patch have to say. (And lately, for comic relief, I have been enjoying what "no shares" has to say).
My background inclusive of 10 years of management experience with two of the fastest growing, most successful businesses in America (according to the annual Forbes' rankings at the time)*. That experience has proven helpful to me in evaluating your input. A lot of what I see you write is what I would expect to see, given the circumstance. And depending on the topic presented, sometimes I find your non-responsiveness equally telling. I'm convinced of your legitimacy. And aware, also, that at this juncture, not even the executives are entirely pro-active, and find themselves reacting in a compelling and challenging environment. Totally understandable to me.
Patch, on the other hand, has me at a total disadvantage, being skilled in areas in which I have no experience. On one hand, I find it easy to draw a different conclusion than he does, from the facts he presents. But then, for example, in his study, he predicted that we would see management make a move as we are now seeing, with Vanity. So I give him credit where due. However, the point of my post last night being to present a far different outcome than the one he would have us believe.
I recognize that I am biased, being Long. But the fact remains that your input is more logical, and makes more sense to me. It's really no contest for me to keep my trust in the company.
But really, stox, it's time for the company to live up to the trust we have placed in them. "The numbers are on the way.
Market level poised to explode!" Trust honored at that point.
I was unaware of that NASADQ tab you referenced. I'll look it up.
And thank you, as always.
jay
*Tecnol Medical Products, and The Mentor Corporation. Sold to Kimberly-Clark, and JNJ, rspectively.
News 
Market Data 
Discover 
AI
